POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-182254 | Pharmaceuticals and Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Point of Care Pregnancy and Fertility Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET
7.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Alere
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Ani Biotech Oy
16.3 Beckman Coulter
16.4 bioMerieux
16.5 Church & Dwight
16.6 EKF
16.7 Insight Pharmaceuticals
16.8 Meridian
16.9 OPKO Health
16.10 Polymed Therapeutics
16.11 Polymedco
16.12 Quidel
16.13 Radiometer
16.14 Roche
16.15 Siemens Healthcare
16.16 Trinity
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeHuman chorionic Gonadotropin (hcg) urine test
FSH urine test
Human chorionic Gonadotropin (hcg) blood test
Luteinizing hormone (LH) urine test
By Application
Hypermarkets & supermarkets
Gynaecology & fertility clinics
Pharmacy
Online sales
Drugstores
Companies
Alere
Ani Biotech Oy
Beckman Coulter
bioMerieux
Church & Dwight
EKF
Insight Pharmaceuticals
Meridian
OPKO Health
Polymed Therapeutics
Polymedco
Quidel
Radiometer
Roche
Siemens Healthcare
Trinity
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.